To screen for key quercetin targets against senescence and silicosis, our network pharmacology approach identified 38 overlapping targets, with 10 hub genes identified: IL-6, AKT1, TNF, PTGS2, PPARG, IL-1β, TGF-β1, MMP9, TP53 and JUN. The gene discussed is TP53; the disease is silicosis.